{"id":"W2402233591","doi":"10.1200/jco.2016.67.0182","title":"Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) –Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Cancer Care Ontario; American Society of Clinical Oncology","keywords":"Medicine; Trastuzumab; Oncology; Docetaxel; Internal medicine; Guideline; Breast cancer; Taxane; Regimen; Carboplatin; Context (archaeology); Population; Anthracycline; Cancer; Gynecology; Chemotherapy; Pathology; Cisplatin","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01310233,0.000382511,0.004139156,0.0001235546,0.0001319188,0.000007853254,0.0004863757,0.0009173761,0.0003023848],"category_scores_gemma":[0.01068757,0.0002273879,0.001656426,0.0003180601,0.00226991,0.0003214072,0.00009678935,0.0015335,3.641042e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00167895,"about_ca_system_score_gemma":0.01871192,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02210665,"about_ca_topic_score_gemma":0.02369811,"domain_scores_codex":[0.9857831,0.002837915,0.009220058,0.0007313035,0.0008825757,0.000545053],"domain_scores_gemma":[0.9622346,0.0131315,0.01189666,0.0004184885,0.01174967,0.0005691337],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.06594611,0.003583873,0.1210725,0.0001093416,0.002861419,0.000006514113,0.003514677,0.00007741615,0.00469206,0.00003460938,0.02716114,0.7709404],"study_design_scores_gemma":[0.06175664,0.1823955,0.5112915,0.0007910993,0.001428797,0.000158994,0.009443157,0.002335298,0.008310781,0.0001682801,0.2214287,0.0004912784],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9329226,0.0007421565,0.01217149,0.04881552,0.001576572,0.002954229,0.0007120868,0.00001627173,0.00008907947],"genre_scores_gemma":[0.7592621,0.00762028,0.2233397,0.005780354,0.003612057,0.0001076565,0.00004561904,0.000095746,0.0001364857],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7704491,"threshold_uncertainty_score":0.9976458,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1880175702403382,"score_gpt":0.5514264082407141,"score_spread":0.3634088380003759,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}